Cardio-oncology & otherGuideline or statement
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- Clinical consensus statement
Recommendations
As issued by the authors
Risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination.
Disease-related forms are generally more common and severe than vaccination-related forms.
Vaccination increases myocarditis risk, but this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting vaccine use.
Original publication
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. Published 20 May 2025. doi:10.1093/eurheartj/ehaf222
Summarised from the published abstract; every number is checked against it